Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-05-13

AUTHORS

Brenda M Westerhuis, Sara CM Jonker, Sandhia Mattao, Kimberley SM Benschop, Katja C Wolthers

ABSTRACT

BackgroundHuman parechoviruses (HPeVs) are among the most frequently detected picornaviruses in humans. HPeVs are usually associated with mild gastrointestinal and respiratory symptoms with the exception of HPeV3 which causes neonatal sepsis and CNS infection. Previous studies showed various results in culturing different HPeV genotypes, inducing only a low cytopathic effect (CPE).MethodsIn vitro growth characteristics of the different HPeV genotypes in a range of 10 different cell lines are scored with CPE and measured in the supernatant by real time PCR. In the optimal cell line for each genotype a standard neutralization assay with the available HPeV antibodies (Abs) was performed and scored by CPE and measured by real time PCR.ResultsAll six HPeV types were able to replicate on the RD99, A549, and Vero cell lines. HPeV1 was the only genotype able to replicate on all cell lines. Most efficient growth of HPeV1, 2, 4, 5, and 6 was shown on the HT29 cell line, while HPeV3 was unable to replicate on HT29. In all cases viral replication could be measured by real time PCR before CPE appeared. The polyclonal Abs available against HPeV1, 2, 4 and 5 all showed neutralization of their respective genotype after 7 days with inhibition of >60% in real time PCR and full inhibition of CPE, although cross-neutralization is shown. Replication of HPeV3 could only be inhibited by 12% by the anti-HPeV3 (aHPeV3) Ab and no inhibition of CPE was shown after 7 days.ConclusionWhen replication is monitored by PCR, growth of HPeV genotypes 1 to 6 is supported by most of the cell lines tested, where viral replication is measured before appearance of CPE. A combination of HT29 and Vero cells would therefore support replication of all culturable HPeV types, so viral replication could be detected by PCR within 3 days for all genotypes.In addition, we showed efficient neutralization for HPeV1, 2, 4, 5, while cross- neutralization was shown between these types, indicating possible common neutralizing epitopes. For HPeV3 no efficient (cross-) neutralization was shown, indicating different neutralizing epitopes for HPeV3 compared to the other HPeV genotypes. More... »

PAGES

146

References to SciGraph publications

  • 1996-09. Characterization of echovirus 22 variants in ARCHIVES OF VIROLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/1743-422x-10-146

    DOI

    http://dx.doi.org/10.1186/1743-422x-10-146

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1010693573

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/23668373


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical Microbiology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Neutralizing", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross Reactions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytopathogenic Effect, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neutralization Tests", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Parechovirus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Real-Time Polymerase Chain Reaction", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5650.6", 
              "name": [
                "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Westerhuis", 
            "givenName": "Brenda M", 
            "id": "sg:person.01206262137.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206262137.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5650.6", 
              "name": [
                "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jonker", 
            "givenName": "Sara CM", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5650.6", 
              "name": [
                "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mattao", 
            "givenName": "Sandhia", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5650.6", 
              "name": [
                "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Benschop", 
            "givenName": "Kimberley SM", 
            "id": "sg:person.014170360114.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014170360114.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5650.6", 
              "name": [
                "Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wolthers", 
            "givenName": "Katja C", 
            "id": "sg:person.01322117344.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322117344.51"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf01718297", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003045447", 
              "https://doi.org/10.1007/bf01718297"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2013-05-13", 
        "datePublishedReg": "2013-05-13", 
        "description": "BackgroundHuman parechoviruses (HPeVs) are among the most frequently detected picornaviruses in humans. HPeVs are usually associated with mild gastrointestinal and respiratory symptoms with the exception of HPeV3 which causes neonatal sepsis and CNS infection. Previous studies showed various results in culturing different HPeV genotypes, inducing only a low cytopathic effect (CPE).MethodsIn vitro growth characteristics of the different HPeV genotypes in a range of 10 different cell lines are scored with CPE and measured in the supernatant by real time PCR. In the optimal cell line for each genotype a standard neutralization assay with the available HPeV antibodies (Abs) was performed and scored by CPE and measured by real time PCR.ResultsAll six HPeV types were able to replicate on the RD99, A549, and Vero cell lines. HPeV1 was the only genotype able to replicate on all cell lines. Most efficient growth of HPeV1, 2, 4, 5, and 6 was shown on the HT29 cell line, while HPeV3 was unable to replicate on HT29. In all cases viral replication could be measured by real time PCR before CPE appeared. The polyclonal Abs available against HPeV1, 2, 4 and 5 all showed neutralization of their respective genotype after 7 days with inhibition of >60% in real time PCR and full inhibition of CPE, although cross-neutralization is shown. Replication of HPeV3 could only be inhibited by 12% by the anti-HPeV3 (aHPeV3) Ab and no inhibition of CPE was shown after 7 days.ConclusionWhen replication is monitored by PCR, growth of HPeV genotypes 1 to 6 is supported by most of the cell lines tested, where viral replication is measured before appearance of CPE. A combination of HT29 and Vero cells would therefore support replication of all culturable HPeV types, so viral replication could be detected by PCR within 3 days for all genotypes.In addition, we showed efficient neutralization for HPeV1, 2, 4, 5, while cross- neutralization was shown between these types, indicating possible common neutralizing epitopes. For HPeV3 no efficient (cross-) neutralization was shown, indicating different neutralizing epitopes for HPeV3 compared to the other HPeV genotypes.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/1743-422x-10-146", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1034449", 
            "issn": [
              "1743-422X"
            ], 
            "name": "Virology Journal", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "10"
          }
        ], 
        "keywords": [
          "real-time PCR", 
          "cytopathic effect", 
          "viral replication", 
          "time PCR", 
          "cell lines", 
          "inhibition of CPE", 
          "HPeV types", 
          "appearance of CPE", 
          "standard neutralization assay", 
          "vitro growth characteristics", 
          "human parechovirus 1", 
          "respiratory symptoms", 
          "neonatal sepsis", 
          "CNS infection", 
          "different cell lines", 
          "low cytopathic effect", 
          "efficient neutralization", 
          "optimal cell line", 
          "neutralization assays", 
          "HT29 cell line", 
          "HPeV3", 
          "parechovirus 1", 
          "Vero cell line", 
          "polyclonal Ab", 
          "HPeV1", 
          "Vero cells", 
          "HPeV", 
          "inhibition", 
          "PCR", 
          "antibodies", 
          "epitopes", 
          "days", 
          "full inhibition", 
          "HT29", 
          "respective genotypes", 
          "genotypes", 
          "neutralization", 
          "sepsis", 
          "only genotype", 
          "previous studies", 
          "replication", 
          "symptoms", 
          "parechovirus", 
          "infection", 
          "Ab", 
          "growth characteristics", 
          "A549", 
          "supernatant", 
          "assays", 
          "effect", 
          "cells", 
          "picornaviruses", 
          "humans", 
          "lines", 
          "types", 
          "study", 
          "appearance", 
          "growth", 
          "characteristics", 
          "exception", 
          "combination", 
          "efficient growth", 
          "addition", 
          "comparison", 
          "results", 
          "range"
        ], 
        "name": "Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR", 
        "pagination": "146", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1010693573"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/1743-422x-10-146"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "23668373"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/1743-422x-10-146", 
          "https://app.dimensions.ai/details/publication/pub.1010693573"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:39", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_610.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/1743-422x-10-146"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-10-146'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-10-146'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-10-146'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-10-146'


     

    This table displays all metadata directly associated to this object as RDF triples.

    200 TRIPLES      21 PREDICATES      103 URIs      94 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/1743-422x-10-146 schema:about N01b4824ce2944814a452a6a20734bf9c
    2 N056c77c43056438c8263508f05e38e9c
    3 N33c3a2068c6f410ba06cad940880b8fb
    4 N3c47c02b226b4970be21c6c602bad3d2
    5 N44c8d014dd364ef48fac3f4bfc47a110
    6 N4a35474dd9f9409cb4990b4357bf9eec
    7 N652cac437360496e83716bc28ca93220
    8 N6630d385771a4af9a380c6c06dadda6e
    9 Na0fade82902341dbb5590b19fc1742d8
    10 Nd750d121061c48faad27e074bf511635
    11 Nfbbac0aab89042aaad093b50844284ea
    12 anzsrc-for:11
    13 anzsrc-for:1108
    14 schema:author N75a948cd850143b2b3fa07f8950f0e13
    15 schema:citation sg:pub.10.1007/bf01718297
    16 schema:datePublished 2013-05-13
    17 schema:datePublishedReg 2013-05-13
    18 schema:description BackgroundHuman parechoviruses (HPeVs) are among the most frequently detected picornaviruses in humans. HPeVs are usually associated with mild gastrointestinal and respiratory symptoms with the exception of HPeV3 which causes neonatal sepsis and CNS infection. Previous studies showed various results in culturing different HPeV genotypes, inducing only a low cytopathic effect (CPE).MethodsIn vitro growth characteristics of the different HPeV genotypes in a range of 10 different cell lines are scored with CPE and measured in the supernatant by real time PCR. In the optimal cell line for each genotype a standard neutralization assay with the available HPeV antibodies (Abs) was performed and scored by CPE and measured by real time PCR.ResultsAll six HPeV types were able to replicate on the RD99, A549, and Vero cell lines. HPeV1 was the only genotype able to replicate on all cell lines. Most efficient growth of HPeV1, 2, 4, 5, and 6 was shown on the HT29 cell line, while HPeV3 was unable to replicate on HT29. In all cases viral replication could be measured by real time PCR before CPE appeared. The polyclonal Abs available against HPeV1, 2, 4 and 5 all showed neutralization of their respective genotype after 7 days with inhibition of >60% in real time PCR and full inhibition of CPE, although cross-neutralization is shown. Replication of HPeV3 could only be inhibited by 12% by the anti-HPeV3 (aHPeV3) Ab and no inhibition of CPE was shown after 7 days.ConclusionWhen replication is monitored by PCR, growth of HPeV genotypes 1 to 6 is supported by most of the cell lines tested, where viral replication is measured before appearance of CPE. A combination of HT29 and Vero cells would therefore support replication of all culturable HPeV types, so viral replication could be detected by PCR within 3 days for all genotypes.In addition, we showed efficient neutralization for HPeV1, 2, 4, 5, while cross- neutralization was shown between these types, indicating possible common neutralizing epitopes. For HPeV3 no efficient (cross-) neutralization was shown, indicating different neutralizing epitopes for HPeV3 compared to the other HPeV genotypes.
    19 schema:genre article
    20 schema:isAccessibleForFree true
    21 schema:isPartOf Nbaf3d1a311c1474aa72d124cbfdfee44
    22 Nd9929c626c484aa1bd3e4c741476bacd
    23 sg:journal.1034449
    24 schema:keywords A549
    25 Ab
    26 CNS infection
    27 HPeV
    28 HPeV types
    29 HPeV1
    30 HPeV3
    31 HT29
    32 HT29 cell line
    33 PCR
    34 Vero cell line
    35 Vero cells
    36 addition
    37 antibodies
    38 appearance
    39 appearance of CPE
    40 assays
    41 cell lines
    42 cells
    43 characteristics
    44 combination
    45 comparison
    46 cytopathic effect
    47 days
    48 different cell lines
    49 effect
    50 efficient growth
    51 efficient neutralization
    52 epitopes
    53 exception
    54 full inhibition
    55 genotypes
    56 growth
    57 growth characteristics
    58 human parechovirus 1
    59 humans
    60 infection
    61 inhibition
    62 inhibition of CPE
    63 lines
    64 low cytopathic effect
    65 neonatal sepsis
    66 neutralization
    67 neutralization assays
    68 only genotype
    69 optimal cell line
    70 parechovirus
    71 parechovirus 1
    72 picornaviruses
    73 polyclonal Ab
    74 previous studies
    75 range
    76 real-time PCR
    77 replication
    78 respective genotypes
    79 respiratory symptoms
    80 results
    81 sepsis
    82 standard neutralization assay
    83 study
    84 supernatant
    85 symptoms
    86 time PCR
    87 types
    88 viral replication
    89 vitro growth characteristics
    90 schema:name Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR
    91 schema:pagination 146
    92 schema:productId N317875a0e9e34f6195290b4bbe97f693
    93 Nadfadafcf4d248b9b4f155332dbf6909
    94 Nd6554c5bb1504f8d84f112120770e512
    95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010693573
    96 https://doi.org/10.1186/1743-422x-10-146
    97 schema:sdDatePublished 2022-10-01T06:39
    98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    99 schema:sdPublisher Nb1fcd9fa2d89429e9d2d42b3afdcd4f0
    100 schema:url https://doi.org/10.1186/1743-422x-10-146
    101 sgo:license sg:explorer/license/
    102 sgo:sdDataset articles
    103 rdf:type schema:ScholarlyArticle
    104 N01b4824ce2944814a452a6a20734bf9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Parechovirus
    106 rdf:type schema:DefinedTerm
    107 N056c77c43056438c8263508f05e38e9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Antibodies, Viral
    109 rdf:type schema:DefinedTerm
    110 N0b25f624284042ad865a32fc384666d5 schema:affiliation grid-institutes:grid.5650.6
    111 schema:familyName Mattao
    112 schema:givenName Sandhia
    113 rdf:type schema:Person
    114 N30e20f2f0e834c71897655bc8a3846f0 rdf:first sg:person.014170360114.04
    115 rdf:rest N8b985ca8d90c460880ca0954ed1ef805
    116 N317875a0e9e34f6195290b4bbe97f693 schema:name pubmed_id
    117 schema:value 23668373
    118 rdf:type schema:PropertyValue
    119 N33c3a2068c6f410ba06cad940880b8fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Cross Reactions
    121 rdf:type schema:DefinedTerm
    122 N3c47c02b226b4970be21c6c602bad3d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Real-Time Polymerase Chain Reaction
    124 rdf:type schema:DefinedTerm
    125 N44c8d014dd364ef48fac3f4bfc47a110 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Animals
    127 rdf:type schema:DefinedTerm
    128 N4a35474dd9f9409cb4990b4357bf9eec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name RNA, Viral
    130 rdf:type schema:DefinedTerm
    131 N652cac437360496e83716bc28ca93220 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Humans
    133 rdf:type schema:DefinedTerm
    134 N6630d385771a4af9a380c6c06dadda6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Cell Line
    136 rdf:type schema:DefinedTerm
    137 N6a4ed0ffdf61411aab51dce8d23490e6 rdf:first N0b25f624284042ad865a32fc384666d5
    138 rdf:rest N30e20f2f0e834c71897655bc8a3846f0
    139 N75a948cd850143b2b3fa07f8950f0e13 rdf:first sg:person.01206262137.10
    140 rdf:rest Ne5205ae664fd44889881562f366ffa91
    141 N8b985ca8d90c460880ca0954ed1ef805 rdf:first sg:person.01322117344.51
    142 rdf:rest rdf:nil
    143 Na0fade82902341dbb5590b19fc1742d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Neutralization Tests
    145 rdf:type schema:DefinedTerm
    146 Nadfadafcf4d248b9b4f155332dbf6909 schema:name dimensions_id
    147 schema:value pub.1010693573
    148 rdf:type schema:PropertyValue
    149 Nb1fcd9fa2d89429e9d2d42b3afdcd4f0 schema:name Springer Nature - SN SciGraph project
    150 rdf:type schema:Organization
    151 Nbaf3d1a311c1474aa72d124cbfdfee44 schema:volumeNumber 10
    152 rdf:type schema:PublicationVolume
    153 Nd6554c5bb1504f8d84f112120770e512 schema:name doi
    154 schema:value 10.1186/1743-422x-10-146
    155 rdf:type schema:PropertyValue
    156 Nd750d121061c48faad27e074bf511635 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Cytopathogenic Effect, Viral
    158 rdf:type schema:DefinedTerm
    159 Nd9929c626c484aa1bd3e4c741476bacd schema:issueNumber 1
    160 rdf:type schema:PublicationIssue
    161 Ndd619a118c6b41a483d6219bbc741ee4 schema:affiliation grid-institutes:grid.5650.6
    162 schema:familyName Jonker
    163 schema:givenName Sara CM
    164 rdf:type schema:Person
    165 Ne5205ae664fd44889881562f366ffa91 rdf:first Ndd619a118c6b41a483d6219bbc741ee4
    166 rdf:rest N6a4ed0ffdf61411aab51dce8d23490e6
    167 Nfbbac0aab89042aaad093b50844284ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Antibodies, Neutralizing
    169 rdf:type schema:DefinedTerm
    170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    171 schema:name Medical and Health Sciences
    172 rdf:type schema:DefinedTerm
    173 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
    174 schema:name Medical Microbiology
    175 rdf:type schema:DefinedTerm
    176 sg:journal.1034449 schema:issn 1743-422X
    177 schema:name Virology Journal
    178 schema:publisher Springer Nature
    179 rdf:type schema:Periodical
    180 sg:person.01206262137.10 schema:affiliation grid-institutes:grid.5650.6
    181 schema:familyName Westerhuis
    182 schema:givenName Brenda M
    183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206262137.10
    184 rdf:type schema:Person
    185 sg:person.01322117344.51 schema:affiliation grid-institutes:grid.5650.6
    186 schema:familyName Wolthers
    187 schema:givenName Katja C
    188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322117344.51
    189 rdf:type schema:Person
    190 sg:person.014170360114.04 schema:affiliation grid-institutes:grid.5650.6
    191 schema:familyName Benschop
    192 schema:givenName Kimberley SM
    193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014170360114.04
    194 rdf:type schema:Person
    195 sg:pub.10.1007/bf01718297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003045447
    196 https://doi.org/10.1007/bf01718297
    197 rdf:type schema:CreativeWork
    198 grid-institutes:grid.5650.6 schema:alternateName Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands
    199 schema:name Department of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZAZ, The Netherlands
    200 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...